Main Article Content

S. Seshadhri
P. Poncheran
N. Venkateswaramurthy


Generic and branded medicine, ADR.


Background: Most people in India were not aware of generic drugs. Limited studies were conducted in the country regarding the usage and ADR of allopathy medicine.  


Objectives: The study’s objective is to find out the knowledge about allopathic medicine and its generic counterpart among participants. We also assess the awareness about the ADR of allopathic medicine.

Methods: The cross-sectional study was conducted through an online web survey over six months. We Distributed the questionnaire via the online platform.

Results: A total of n=273 responses were obtained, which was concentrated to n=201. Of 201 participants, around 30% hadn’t heard the phrase generic medicine. Around n=121(60.25%) of the population needed to ensure medicine availability in generic stores. Over n= 48, (23.88%) of participants were not aware of ADR.

Conclusions: We concluded that the people had enough knowledge about generic drugs but lacked awareness of the locations and availability of generic medicines in their local area; the Government taking necessary actions to promote generic drugs would help reduce the economic burden on branded ones. Individuals who take medications should be educated about potential side effects and how to address them.

Abstract 124 | pdf Downloads 50


1. Ujala V, Rashmi S, Pankaj G, Samta G, Bhuvneshvar K. Allopathic vs. ayurvedic practices in tertiary care institutes of urban North India. Indian Journal of Pharmacology. 2007;39(1):52-55. DOI: 10.4103/0253-7613.30765.
2. Blum, Eliana M. Allopathic Medicine’s Influence on Indigenous Peoples in the Kumaon Region of India. Butler Journal of Undergraduate Research. 2018;4(3):22- 50. Available from: https://digitalcommons.butler.edu/bjur/vol4/iss1/3.
3. Darshan Shankar. Health sector reforms for 21st century healthcare. Journal of Ayurveda & Integrative Medicine. 2015;6(1):4-9. PMID: 25878456.
4. Kanchan M. A Cost Analysis of the Jan Aushadhi Scheme in India. International Journal of Health Policy and Management. 2017;6(5):253–256. DOI: 10.15171/IJHPM.2017.02.
5. Dighe SV. A Review of the Safety of Generic Drugs. Transplantation proceedings. 1999;31(3):23S-24S. DOI: 10.1016/s0041-1345(99)00109-8.
6. Shailesh T, Sudip B. Patient Perception about Generic vs. Branded Medicines Prescribed in a Tertiary Care Hospital in Northern India -A Descriptive Study. Indian Journal of Pharmacy Practice. 2018;11(2):91-95. DOI: 10.5530/ijopp.11.2.19.
7. Nguyen TA, Knight R, Roughead EE, Brooks G, Mant A. Policy options for pharmaceutical pricing and purchasing: Issues for low- and middle-income countries. Health Policy Plan. 2014;30(2):267-80. DOI: 10.1093/heapol/czt105.
8. Moses A, Cecilia I. Prescribing patterns and perceptions of health care professionals about rational drug use in a specialist. Journal of Public Health in Africa. 2014;5(242):99-103. DOI: 10.4081/jphia.2014.242.
9. World Health Organization. International drug monitoring: the role of the hospital. Geneva, Switzerland: word health organization;1966. Technical report series no.425. Available from: https://apps.who.int/iris/handle/10665/40747.
10. Baniasadi S, Fahimi F, Shalviri G. Developing an adverse drug reaction reporting system at a teaching hospital. Basic Clin Pharmacol Toxicol 2008; 102(4): 408-11. DOI: 10.1111/j.1742-7843.2008.00217.x.
11. Babar ZU, Stewart J, Alzaher W, et al. An evaluation of consumers knowledge, perceptions and attitudes regarding generic medicines in Auckland. Pharmacy World and Science. 2010;32(4):440-448. DOI: 10.1007/s11096-010-9402-0.
12. Claudio Andre B de L, Jéssica Nathalia S O, Marília dos S A, Cássia Regina V C, Rodrigo Luiz V. Knowledge, perceptions and use of generic drugs: a cross sectional study. Einstein. 2014;12(3):267-273. DOI: 10.1590/s1679-45082014ao3125.
13. Abubaker I E, Nawaf Hasan A, Abdualziz Abdullah A. Knowledge, Attitudes and Practices on Medication Use and Safety among Saudi People: A Public –based Versus an Internet –based Survey in Taif; Kingdom of Saudi Arabia. Saudi Journal of Medical and Pharmaceutical Sciences. 2016;2(6):134-140. DOI:10.21276/sjmps.
14. Fredrik B, Gregory M, Karyn M, Lianne P, Charlotte P. Drug safety awareness in New Zealand: public knowledge and preferred sources for information. Journal of primary health care. 2012; 4(4):288-293. PMID: 23205377.
15. Rasaq A, Omotola Rukayat A, Titilayo Oyelola F. Knowledge, awareness, perception and reporting of experienced adverse drug reactions among outpatients in Nigeria. International Journal of Clinical Pharmacy. 2019; 41:1062–1073. DOI: 10.1007/s11096-019-00849-9